← Open Payments lookup

JESSICA GANDHI: Open Payments

NPI 1003226036 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$11,847 in 136 payments from 25 companies in 2025. Trend: 2023 $880 · 2024 $2,096 · 2025 $11,847

Consulting: $6,210Food & beverage: $4,565Travel & lodging: $521Speaker / faculty: $500Education: $51
CompanyPaymentsAmount
Madrigal Pharmaceuticals28$8,286
Ardelyx, Inc.22$857
Janssen Biotech, Inc.13$679
ABBVIE INC.13$386
Takeda Pharmaceuticals U.S.A., Inc.13$284
GENZYME CORPORATION6$255
QOL Medical, LLC7$182
Janssen Scientific Affairs, LLC1$127
Lilly USA, LLC4$94
Phathom Pharmaceuticals, Inc.5$89

Products named: REZDIFFRA, IBSRELA, TREMFYA, DUPIXENT, ENTYVIO, Sucraid, RINVOQ, SKYRIZI.

Industry payments across MD — which companies pay providers there.